comparemela.com

Quris Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Former Biogen CEO Michel Vounatsos Joins Quris-AI Board

Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand.

United statesFrance generalIsaac bentwichMichel vounatsosYossi ben amramVictor segalenErica camiloBen amramBoard of directors biogen incGlobal human healthConnexa communications forMerck coMerck co incSchool of managementBoards of revvity incTel aviv university

AI-powered pharmaceutical drug testing startup Quris Technologies raises $9M in funding

AI-powered pharmaceutical drug testing startup Quris Technologies raises $9M in funding - SiliconANGLE

Andy jassyIsaac bentwichYossi cohenStarline freepikMichael dellPat gelsingerQuris technologies ltdCube clubRichter groupAmazon web servicesCube event communitySoftbank vision fundYork stem cell foundation research instituteQuris technologiesGlenrock capitalWelltech ventures

Human intestine-on-a-chip for modeling intestinal injury associated with a pediatric inflammatory disorder

News-Medical speaks to Dr. Cicely Fadel and Amir Bein about their latest research which involved the development of an Environmental Enteric Dysfunction (EED) Chip that reveals the effects of nutrition and genetics on disease in children

Israel generalAgha khanUnited statesMarko aliaksandr shutterstockDanielle ellisCicelyw fadelCicely fadelChild health discovery toolsBeth israel deaconess medical centerMelinda gates foundationPerinatal fellowship programHebrew university of jerusalemEquality divisionInstructor in pediatrics at harvard medical schoolResponsibility programYale university

Merck KGaA, Darmstadt, Germany, Enters into Option

BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena,.

United statesRoberts langerErica camiloIsaac bentwichAaaron ciechanoverQuri bioMerck kgaMerck kgaaQuris scientific advisory board memberNobel laureate aaron ciechanoverQuri scientific advisoryQuris technologies

Quris Closes $28 Million in Seed Funding From Top

Industry Strengthens Support for AI Innovator in Push to Close Essential Gaps in Drug Development as Company Prepares for Clinical Testing of the First.

United statesRoberts langerIsaac bentwichKobi richterAaaron ciechanoverQuri bioMoshe yanaiErica camiloGalit horovitzAmir alroyYork stem cell foundationResearch instituteWelltech venturesGlenrock capitalShelly hod moyalNobel laureate aaron ciechanover

vimarsana © 2020. All Rights Reserved.